Fund profile / United States

Vivo Opportunity Fund (Cycle III)

Geography
United States
Stage
Seed
Type
Private equity
Fund size
$740M
Focus
Deep Tech, EdTech and SaaS
Signals
Published
Share
N°01 / About

About Vivo Opportunity Fund (Cycle III)

Global healthcare-specialist investment firm running venture capital, private equity and public equity strategies, with about USD 6.1bn AUM and 16 funds raised. Stage and cheque size not stated.

N°02 / Thesis

Investment Focus

Location / RegionUnited States
Funding StageSeed
Industry Focus
Deep Tech
EdTech
SaaS

Investor Signals Profile

active

Sweet Spot

Clinical-stage biotech founders in oncology/rare disease with global ambitions

biotech/pharma
oncology
innovative therapies
patient outcomes
healthcare access

Bullish Signals

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

Contrarian Signals

Signal text is part of a paid plan
Signal text is part of a paid plan

Founder Do's

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

Founder Don'ts

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

19 signals on Vivo Opportunity Fund (Cycle III)

9 bullish · 2 contrarian · 5 pitch do's · 3 don'ts, each with its source. From €9/month, cancel anytime.

Michael's Network

Facts

Fund Overview

Fund Size$740M
Saves0
People

Key People

Kevin Dai, Gaurav Aggarwal

N°04 / See also

Related Funds

Location
United States
Stage
Growth
Focus
Biotech, Therapeutics
Manager
Dr. Chen Yu, Cariad Chester, Giuliano Marostica
Growth
Biotech
Therapeutics
Location
United States
Stage
Pre Seed
Focus
Robotics Automation, Ai Ml, Biotech
Manager
Arian Ghashghai
Pre Seed
Robotics Automation
Ai Ml
Biotech
Location
United States
Stage
Pre Seed
Focus
Defense, Manufacturing, Infrastructure Tech
Pre Seed
Defense
Manufacturing
Infrastructure Tech
Connect your agent Free to start. No key, no signup.